110 related articles for article (PubMed ID: 23230605)
1. Retraction notice to "Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis" [J. Mol. Cell. Cardiol. 44 (2008) 252–260].
J Mol Cell Cardiol; 2012 Nov; 53(5):744. PubMed ID: 23230605
[No Abstract] [Full Text] [Related]
2. Retraction notice to "Role of glutaredoxin-1 in cardioprotection: an insight with Glrx1 transgenic and knockout animals" [J. Mol. Cell. Cardiol. 44 (2008) 261–269].
J Mol Cell Cardiol; 2012 Nov; 53(5):745. PubMed ID: 23230606
[No Abstract] [Full Text] [Related]
3. Retraction notice to "Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target" [J. Mol. Cell. Cardiol. 42 (2007) 981–990].
J Mol Cell Cardiol; 2012 Nov; 53(5):743. PubMed ID: 23230604
[No Abstract] [Full Text] [Related]
4. Retraction notice to "Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling" [J. Mol. Cell. Cardiol. 41 (2006) 248–255].
J Mol Cell Cardiol; 2012 Nov; 53(5):742. PubMed ID: 23230603
[No Abstract] [Full Text] [Related]
5. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis.
Nagy N; Malik G; Tosaki A; Ho YS; Maulik N; Das DK
J Mol Cell Cardiol; 2008 Feb; 44(2):252-60. PubMed ID: 18076901
[TBL] [Abstract][Full Text] [Related]
6. Retraction notice to "Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury" [Int. J. Cardiol. 163 (2013) 326-334].
Barry SP; Ounzain S; McCormick J; Scarabelli TM; Chen-Scarabelli C; Saravolatz LII; Faggian G; Mazzucco A; Suzuki H; Thiemermann C; Knight RA; Latchman DS; Stephanou A
Int J Cardiol; 2019 Jan; 274():404. PubMed ID: 30449337
[No Abstract] [Full Text] [Related]
7. Retraction notice to Mapping the Future of Myocardial Ischemia Testing With Cardiac Magnetic Resonance: J Am Coll Cardiol 71 (2018) 980-982.
Karamitsos TD
J Am Coll Cardiol; 2020 Oct; 76(16):1917. PubMed ID: 33059841
[No Abstract] [Full Text] [Related]
8. Retraction notice to "Successful treatment for a giant coronary saccular aneurysm complicated with myocardial infarction in a patient with Behcet's disease: Case report" [J Cardiol Cases 6(4) (2012) e118-e120].
Şahin DY; Elbasan Z; Gür M; Huseinov M; Çaylı M
J Cardiol Cases; 2022 Dec; 26(6):436. PubMed ID: 36506500
[TBL] [Abstract][Full Text] [Related]
9. Retraction notice to "Ivabradine as adjuvant treatment for chronic heart failure" [Int. J. Cardiol. 227 (2017) 43-50].
Mizzaci CC; Porfírio GJM; Vilela AT; Guillhen JCS; Riera R
Int J Cardiol; 2017 Nov; 247():55. PubMed ID: 28916091
[No Abstract] [Full Text] [Related]
10. Retraction notice to Diagnosis of Microvascular Angina Using Cardiac Magnetic Resonance: J Am Coll Cardiol 71 (2018) 969-979.
Liu A; Wijesurendra RS; Liu JM; Forfar JC; Channon KM; Jerosch-Herold M; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
J Am Coll Cardiol; 2020 Oct; 76(16):1916. PubMed ID: 33059840
[No Abstract] [Full Text] [Related]
11. Retraction notice to "Prognostic factors for the long-term survival in patients with vasospastic angina--Analysis of effects of patients' characteristics and therapeutic drugs" [J Cardiol 54 (2009) 10-20].
J Cardiol; 2010 Mar; 55(2):285. PubMed ID: 20684042
[No Abstract] [Full Text] [Related]
12. Retraction notice to Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial From Microvascular Coronary Disease: J Am Coll Cardiol 71 (2018) 957-968.
Liu A; Wijesurendra RS; Liu JM; Greiser A; Jerosch-Herold M; Forfar JC; Channon KM; Piechnik SK; Neubauer S; Kharbanda RK; Ferreira VM
J Am Coll Cardiol; 2020 Oct; 76(16):1915. PubMed ID: 33059839
[No Abstract] [Full Text] [Related]
13. Retraction notice to "Long-Term Trends (1986-2003)in the Use of Coronary Reperfusion Strategies in Patients Hospitalized With Acute Myocardial Infarction in Central Massachusetts" [Int. J Cardiol. 131 (2008) (83-89)].
Goldberg RJ; Spencer FA; Okolo J; Lessard D; Yarzebski J; Gore JM
Int J Cardiol; 2017 May; 235():207. PubMed ID: 28342504
[TBL] [Abstract][Full Text] [Related]
14. Notice of Retraction. Shimizu et al. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients. JAMA Cardiol. 2019;4(3):246-254.
Shimizu W; Aiba T
JAMA Cardiol; 2021 Jun; 6(6):727. PubMed ID: 33900377
[No Abstract] [Full Text] [Related]
15. Erratum to "GATA-4 regulation of myocardial survival in the preconditioned heart" [J. Mol. Cell. Cardiol. 37(6) (2004 Dec) 1195-1203].
Suzuki YJ; Nagase H; Day RM; Das DK
J Mol Cell Cardiol; 2016 Dec; 101():25. PubMed ID: 27866047
[No Abstract] [Full Text] [Related]
16. Retraction notice to "Structure and functional analysis of the MYND domain" [J. Mol. Biol. (2006) 358, 498-508].
Spadaccini R; Perrin H; Bottomley MJ; Ansieau S; Sattler M
J Mol Biol; 2008 Mar; 376(5):1523. PubMed ID: 18286714
[No Abstract] [Full Text] [Related]
17. Erratum to "Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis"[J. Mol. Cell Cardiol. 48 (2010) 367-378].
Ceylan-Isik AF; Zhao P; Zhang B; Xiao X; Su G; Ren J
J Mol Cell Cardiol; 2016 Aug; 97():306-307. PubMed ID: 27566196
[No Abstract] [Full Text] [Related]
18. Retraction notice to: “The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages” [J. Steroid Biochem. Mol. Biol. 103 (2007) 558–562].
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):444. PubMed ID: 22200063
[No Abstract] [Full Text] [Related]
19. Retraction notice to "Novel synthetic approach to 1alpha, 25-dihydroxyvitamin D3 and analogues" [J. Steroid Biochem. Mol. Biol 103 (2007) 231-234].
Mouriño A
J Steroid Biochem Mol Biol; 2008 Jan; 108(1-2):178. PubMed ID: 18345556
[No Abstract] [Full Text] [Related]
20. Retraction notice to “Peroxisome proliferator-activated receptor α controls hepatic heme biosynthesis through ALAS1” J. Mol. Biol. 388/2 (2010) 225–238.
J Mol Biol; 2010 Nov; 404(1):172. PubMed ID: 21077284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
